Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm
Translocation of (6;8)(p21;q24), a recurrent abnormality of blastic plasmacytoid dendritic cell neoplasm, involves adjacent MYC and RUNX2 regions. Here, the authors show that the RUNX2 super-enhancer is hijacked to activate MYC in addition to RUNX2 expression, promoting the development of this cance...
Guardado en:
Autores principales: | Sho Kubota, Kenji Tokunaga, Tomohiro Umezu, Takako Yokomizo-Nakano, Yuqi Sun, Motohiko Oshima, Kar Tong Tan, Henry Yang, Akinori Kanai, Eisaku Iwanaga, Norio Asou, Takahiro Maeda, Naomi Nakagata, Atsushi Iwama, Kazuma Ohyashiki, Motomi Osato, Goro Sashida |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b55f6237adba4583b97db796afe3c64f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm
por: Sho Kubota, et al.
Publicado: (2019) -
Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects
por: Trottier AM, et al.
Publicado: (2017) -
Runx family genes in a cartilaginous fish, the elephant shark (Callorhinchus milii).
por: Giselle Sek Suan Nah, et al.
Publicado: (2014) -
Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia
por: Yotaro Ochi, et al.
Publicado: (2021) -
Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma.
por: Kazuma Ohyashiki, et al.
Publicado: (2011)